The Food and Drug Administration has begun to hold a series of patient meetings to gain a better understanding of specific diseases. Over the next five years, the agency plans to conduct at least 20 such meetings on conditions ranging from Chronic Fatigue Syndrome to Narcolepsy to Irritable Bowel Syndrome.
But not diabetes.
That is unacceptable.
Four “slots” remain open (view the current list), and we want the FDA to add diabetes to its meeting docket for 2013.
According to the American Diabetes Association, nearly 26 million Americans have either type 1 or type 2 diabetes, and an additional 79 million have prediabetes. Those numbers are also increasing each year – the CDC estimates that if current trends continue, one in three US adults will have diabetes by 2050.
No one disputes that diabetes is one of America’s – and the world’s – most serious health epidemics. In 2012, more than one in five total US healthcare dollars was spent on care for people with diabetes. The estimated costs of diagnosed diabetes totaled $245 billion, and everyone is paying for this epidemic. Despite growing needs, research dollars have also leveled off.
New therapies need to be investigated, tested, and brought to market, and as part of that process, the FDA must understand the daily challenges that patients face.
We need to tell our story to the FDA: about the need for accurate strips, more physiologic insulin, a broader range of drugs, and the Artificial Pancreas.
Our voices need to be heard.
Please sign this petition to urge the FDA to sponsor a patient meeting focused on diabetes – and the sooner, the better.
Thank you very much.